Tetra Pharm Technologies announces successful In-Vitro drug release test of new analgesic compound
The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug -…
We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
14 Jun 23
The Danish biotech company, Tetra Pharm Technologies, announces promising results from preclinical testing of its pain-relieving drug -…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Jun 23
Under the partnership, Charles River will use its contract development and manufacturing organisation expertise in HQ plasmid DNA…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
09 Jun 23
Under the agreement, AstraZeneca will harness Quell's distinctive arsenal of Treg cell engineering modules, which includes the groundbreaking…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Jun 23
BogotáBio, implementing an innovative collaboration model between the public and private sectors in the pharmaceutical sector in Bogota,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
02 Jun 23
In addition to the transactions, Eikon has concluded the initial portion of a Series C equity financing, securing…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
01 Jun 23
Cobitolimod, a TLR9 agonist, is currently undergoing evaluation in the global phase III programme, known as CONCLUDE, as…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
29 May 23
Inpefa is an oral inhibitor of sodium-glucose cotransporter types 2 and 1 (SGLT2 and SGLT1), administered as a…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
25 May 23
With an extensive pipeline focused on DDR and strategic partnerships with global pharmaceutical companies, Artios has chosen ANGLE…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
24 May 23
Post-merger, the combined firm, which is expected to operate as TuHURA Biosciences and trade on Nasdaq Capital Market,…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
23 May 23
VectivBio’s lead investigational product is apraglutide, a next-generation, long-acting synthetic GLP-2 analog in phase 3, which is being…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates